Align Technology Inc. (ALGN) exhibits 67.2% gross margins and 11.1% return on invested capital within Health Care (Industrial Specialties), balanced against a 17.0x enterprise multiple and 6.6% implied options volatility.
Sustained 67.2% gross profitability converts into 13.5% operating margin and 11.1% ROIC, outpacing sector cost of capital.
ROIC: 11.1% // GM: 67.2%YoY revenue trajectory of +0.9% paired with 4.49% free cash flow yield supports self-funded R&D and capital return.
REV YOY: +0.9% // FCF YLD: 4.49%Altman Z-Score of 4.62 and Piotroski F-Score of 7/9 indicate low near-term refinancing stress.
ALTMAN Z: 4.62 // F-SCORE: 7/9Trading at 26.6x trailing P/E (24.7x Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 26.6x // EV/EBITDA: 17.0xOptions market prices a ±6.6% implied move with a 0.85 put/call ratio around $151.00 max pain.
IMPL MOVE: ±6.6% // P/C: 0.85Elevated industry capital intensity and customer concentration in Industrial Specialties require continuous execution to defend 10.2% net margins.
NET MARGIN: 10.2% // D/E: 0.23x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for ALGN & activate live FRED threshold breach alerts.